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Abstract
TGF- activates receptor-regulated Smad (R-Smad) through phosphorylation 
by type I receptors. Activated R-Smad binds to Smad4 and the complex 
translocates into the nucleus and stimulates the transcription of target genes 
through association with co-activators including p300. It is not clear, however, how 
activated Smad complexes are removed from target genes. In this study, we show 
that TGF- enhances the mono-ubiquitination of Smad4. Smad4 
mono-ubiquitination was promoted by p300 and suppressed by the c-Ski 
co-repressor. Smad4 mono-ubiquitination disrupted the interaction with Smad2 in 
the presence of constitutively active TGF- type I receptor. Furthermore, 
mono-ubiquitinated Smad4 was not found in DNA-binding Smad complexes. A 
Smad4-Ubiquitin fusion protein, which mimics mono-ubiquitinated Smad4, 
enhanced localization to the cytoplasm. These results suggest that 
mono-ubiquitination of Smad4 occurs in the transcriptional activator complex and 
facilitates the turnover of Smad complexes at target genes.
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Introduction
The transforming growth factor- (TGF-) family of extracellular growth factors 
regulates cell proliferation, differentiation, apoptosis, and morphogenesis [1, 2]. Upon 
ligand binding, type II receptors activate type I receptors which in turn transduce 
intracellular signals through phosphorylation of Smad proteins. Smad proteins are 
classified into three groups: receptor-regulated Smad (R-Smad), common partner Smad 
(Co-Smad), and inhibitory Smad (I-Smad). Smad1, Smad5 and Smad8 are 
phosphorylated by bone morphogenetic protein (BMP) receptors, whereas Smad2 and 
Smad3 are phosphorylated by TGF-/activin receptors. Phosphorylated R-Smad forms a 
functional signaling complex with Smad4 (Co-Smad) and translocates into the nucleus 
to regulate the expression of ligand-responsive genes [3]. Activated Smad complexes 
bind directly to the AGAC box or related DNA sequences in target genes and recruit 
coactivators, including p300/CBP [4, 5].  p300/CBP stimulates transcription through 
acetylation of histones. However, it is not clear how activated Smad complexes 
dissociate from target genes. Proteasome-mediated degradation of Smad3 following 
ubiquitination by the ROC1-SCFFbw1a E3 ubiquitin ligase complex was found to arrest 
TGF- signaling [6]. Although Smad4 mono-ubiquitination has been reported [7], the 
functional significance of this modification has not been determined. 
Recent studies have suggested a link between the activator function of many 
transcription factors and their ubiquitination/degradation [8]. Sequences targeted by the 
degradation machinery (“degrons”) and those required for transcriptional activation 
often overlap and can, in fact, be functionally equivalent [9]. For example, Gal4 
ubiquitination and destruction are required for transcriptional activation by Gal4 in 
yeast. Ubiquitination occurs at a post-initiation step in transcription [10]. In mammalian 
cells, ubiquitination of c-Myc, Tat and CIITA transcription factors stimulates 
transcriptional activation [11-14]. In this study, we show that TGF- stimulates the 
mono-ubiquitination of Smad4. Smad4 mono-ubiquitination was positively and 
negatively regulated by co-activator p300 and co-repressor c-Ski, respectively.
Materials and methods
Cells. 293T and COS-7 cells were obtained from the American Type Culture Collection. 
HaCaT cells were obtained from Dr. N.E. Fusenig. These cells were cultured in 
Dulbecco’s modified Eagle’s medium (Sigma) supplemented with 10 % fetal bovine 
serum (FBS) and penicillin-streptomycin solution (Gibco). HaCaT cells stably 
expressing FLAG-Ubiquitin were selected and maintained in medium containing 1 
µg/ml puromycin (Sigma).
DNA constructs and transfection. Expression constructs encoding ALK-5(TD), 
Ubiquitin, Smads, p300 and c-Ski were described previously [6, 15]. FLAG-Ubiquitin 
was cloned into the pCAG-IP vector [16] and used to establish stable transfectants. The 
Smad4-Ubiquitin fusion protein was generated using a PCR-based method. Cells were 
transfected using FuGENE 6 transfection reagent (Roche Diagnostics) according to the 
manufacturer’s recommendations.  
Immunoprecipitation, DNA affinity precipitation (DNAP) and immunoblotting. For 
immunoprecipitation, cells were solubilized in buffer containing 20 mM Tris-HCl pH 
7.5, 150 mM NaCl, 1 % Nonidet P-40, 1.5 % Trasylol, and 1 mM phenylmethylsulfonyl 
fluoride (PMSF). Cell lysates were cleared by centrifugation. Lysates or 
immunoprecipitates were subjected to SDS-PAGE. Proteins were electrotransferred to 
PVDF membranes (ProBlott, Applied Biosystems) and subjected to immunoblotting. 
Anti-Myc (9E10, Calbiochem), anti-hemagglutinin (HA) (3F10, Roche), anti-FLAG 
(M2, Sigma), anti-Smad4 (B8, Santa Cruz) and anti-phospho-Smad2 [17] antibodies 
were used as primary antibodies. Reacted antibodies were detected using an enhanced 
chemiluminescence detection system (Amersham Pharmacia Biotech). For re-blotting, 
membranes were stripped according to the manufacturer’s protocol. 
DNA affinity precipitation was performed as reported [18] using biotinylated 
oligo-DNA (3×CAGA probe) and streptavidin-agarose beads (Sigma) for precipitation.
Sequence of 3×CAGA probe was as follows:
Sense strand, 
5’-TCGAGAGCCAGACAAGGAGCCAGACAAGGAGCCAGACACTCGAG-3’
Antisense strand, 
5’-CTCGAGTGTCTGGCTCCTTGTCTGGCTCCTTGTCTGGCTCTCGA-3’
Immunofluorescence. Immunohistochemical staining of FLAG-Smad4 and 
FLAG-Smad4-Ub in transfected COS-7 cells was performed using anti-FLAG (M2) 
antibody followed by incubation with Alexa 488-labeled goat anti-mouse IgG 
(Molecular Probes). Nuclei were stained with Hoechst33342 (Sigma). Intracellular 
localization was observed by fluorescence microscopy (Axiovert 200, Zeiss).
Results and Discussion
TGF- stimulates mono-ubiquitination of Smad4. 
Mono- or poly-ubiquitination of Smad4 was reported to be important for 
Smad-mediated transcriptional activation [7]. To further investigate the roles of Smad4 
mono-ubiquitination in TGF- signaling, FLAG-Smad4 and HA-Ubiquitin cDNAs were 
transfected in 293T cells and the mono-ubiquitination of Smad4 was examined in the 
absence or presence of TGF-Fig. 1A). As reported previously [7], Smad4 
mono-ubiquitination occurred in the absence of TGF-, and was further enhanced by 
TGF- (Fig. 1A). We could not detect the ubiquitination of Smad2 with or without 
TGF- stimulation (data not shown). We next established HaCaT cells stably expressing 
FLAG-tagged Ubiquitin (Fig. 1B). Using this cell line, we investigated the 
ubiquitination of endogenous Smad4. Following TGF- treatment, Smad4 was 
immunoprecipitated and subjected to immunoblot analysis with anti-FLAG antibody. 
Mono-ubiquitinated Smad4 was detected at 1 - 2 hours after treatment with TGF-  and 
decreased in abundance at 4 hours (Fig. 1C). Phosphorylation of Smad2 peaked at 1 
hour after treatment and gradually declined. These results indicate that TGF- signaling 
stimulates mono-ubiquitination of Smad4.
Effects of p300 and c-Ski on the mono-ubiquitination of Smad4. 
p300 enhances ubiquitination of Smad3 by recruiting the ROC1-SCFFbw1a E3 
ubiquitin ligase complex [6]. We examined the effects of p300 on the 
mono-ubiquitination of Smad4. p300 was coexpressed with Smad4, FLAG-Ubiquitin, 
and a constitutively active form of TGF-β type I receptor (ALK-5(TD)-HA) in 293T 
cells (Fig. 2A). Coexpression of p300 induced a shift in Smad4 mobility consistent with 
Smad4 mono-ubiquitination. In contrast, the mobility of Smad2 did not change (Fig. 
2A). We observed non-ubiquitinated Myc-Smad4 and Myc-Smad2 in FLAG-Ubiquitin 
immunoprecipitates, suggesting that Ubiquitin forms non-covalent associations with 
these proteins in the absence of p300, and that covalent Ubiquitin linkages are promoted 
by p300. The mobility shift of Smad4 induced by p300 was also detected using an 
anti-Smad4 antibody (Fig. 2B). The binding of c-Ski to Smad2/3 and Smad4, 
dissociates the p300/CBP transcriptional coactivator proteins from Smad complexes 
[19]. We previously showed that c-Ski enhances the DNA binding affinity of Smad4 and 
forms a stable c-Ski-Smad complex on Smad binding elements (SBE) [20]. The 
formation of a stable c-Ski-Smad complex on DNA is thought to prevent the 
recruitment of p300 [19]. Therefore, we examined the effects of c-Ski on Smad4 
mono-ubiquitination. As shown in Fig. 2B, c-Ski suppressed the p300-induced 
mono-ubiquitination of Smad4 in a dose dependent manner. 
Ubiquitination of transcription factors including c-Myc and CIITA has been shown 
to be important for transcriptional activation. Skp2-mediated ubiquitination and 
proteasome-mediated degradation of c-Myc are required for c-Myc-mediated 
transcription [13, 14]. The impact of CIITA on transcription is also enhanced by its 
poly- and mono-ubiquitination [12]. Several histone acetyltransferases (HATs) including 
p300/CBP, PCAF, and TAF1 have been reported to have intrinsic Ubiquitin ligase 
activities [21]. PCAF, one of HATs, enhances the ubiquitination of CIITA. Furthermore, 
trichostatin A, a broad inhibitor of histone deacetylases (HDACs), enhances the 
ubiquitination of CIITA, indicating that CIITA ubiquitination was controlled by HATs 
and HDACs [12]. As shown in Fig. 2, Smad4 mono-ubiquitination was positively and 
negatively regulated by p300 and c-Ski, respectively. These data suggest that 
ubiquitination of transcription factors including Smad4 can be regulated by 
co-activators and co-repressors, although a mechanism for this regulation has not yet 
been determined.
Mono-ubiquitinated Smad4 does not form a stable complex with Smad2 and is released 
from target DNA elements.
Smad4 mono-ubiquitination occurs at Lys507 [7], which is located at the 
interaction interface with phosphorylated R-Smad [22]. Thus, we predicted that 
mono-ubiquitination would release Smad4 from R-Smad. To address this possibility, 
FLAG-Smad4 was coexpressed with Myc-Smad2, HA-Ubiquitin and ALK-5 (TD)-V5 
(Fig. 3A). Mono-ubiquitinated Smad4 was detected after immunoprecipitation with 
anti-FLAG antibody followed by immunoblotting with anti-HA antibody (Fig. 3A, lane 
2). Although an equivalent amount of FLAG-Smad4 was co-immunoprecipitated with 
anti-Myc antibody (Fig. 3A, lane 4, second panel), mono-ubiquitinated Smad4 was not 
found in the Smad2-Smad4 complex (Fig. 3A, lane 4, top panel). This result indicates 
that mono-ubiquitinated Smad4 does not interact with Smad2. Moreover, 
mono-ubiquitinated Smad4 was not found in the Smad complex that is affinity 
precipitated by 3×CAGA probe (Fig. 3B). Mono-ubiquitinated Smad4 was clearly 
detected in the Smad4 immunoprecipitate in the presence of constitutively active 
ALK-5 (Fig. 3B, lane 2, top panel). Although a similar amount of Smad4 was captured 
onto 3×CAGA probe, mono-ubiquitinated Smad4 was not observed (Fig. 3B, lane 3, 4,
top panel). It is not clear whether mono-ubiquitination of Smad4 occurs in the 
Smad4/R-Smad complex or in monomeric Smad4. Because Smad4 has less affinity for 
p300 than does R-Smad [23, 24], p300-mediated mono-ubiquitination of Smad4 is 
thought to occur after the formation of the Smad4/R-Smad complex. 
Subcellular localization of Smad4-Ubiquitin fusion protein.
Mounting evidence suggests that protein mono-ubiquitination can modulate 
cellular localization, transcription, and DNA repair [25-27]. To investigate the function 
of Smad4 mono-ubiquitination, we constructed a Smad4-Ubiqutin fusion protein 
(Smad4-Ub) (Fig. 4A, B). Smad4 has been shown to shuttle rapidly and continuously 
between the cytoplasm and nucleus [28]. In transfected COS-7 cells, Smad4 was 
distributed throughout the cytoplasm and nucleus. In contrast, Smad4-Ub was 
predominantly localized in the cytoplasm. Because leptomycin B (LMB), which inhibits
chromosomal region maintenance 1 (CRM1)-dependent nuclear export, caused 
Smad4-Ub to accumulate in the nucleus, we concluded that the nuclear import of 
Smad4-Ub was intact (Fig. 4C). These results suggest that Smad4-Ub is subject to 
export from the nucleus. In a similar manner, p53-Ubiquitin was found to accumulate in 
the cytoplasm [29], indicating that mono-ubiquitination regulates Smad4 and p53 
trafficking. More studies are needed to investigate how mono-ubiquitinated Smad4 is 
processed (either degraded or deubiquitinated).
The removal of activated Smad complexes from cis-regulatory elements may 
regulate transcription of target genes. An activated Smad complex stimulates 
transcription by binding to the gene-regulatory elements and recruiting co-activators 
including p300 [1, 2]. At the same time, promoter clearance may play a role in 
transcription [8, 9]. Activated Smad proteins can potentially be removed from 
transcription complexes by several mechanisms including Ubiquitin-mediated 
degradation [6] and dephosphorylation [30, 31] of R-Smad. 
In conclusion, TGF-β stimulates mono-ubiquitination of Smad4. The 
mono-ubiquitination of Smad4 may, in turn, dissociate the Smad4/R-Smad complex and 
remove Smad4 from DNA. The proposed scheme of Smad4 mono-ubiquitination is 
shown in Fig. 4D. These results provide novel insight into the mechanism of turnover of 
Smad complexes on target genes.
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Figure legends 
Fig 1. TGF- stimulates mono-ubiquitination of Smad4.
A. 293T cells were transfected with DNA constructs as indicated. Cells were treated 
with TGF-  (100 pM) and cell lysates were immunoprecipitated with anti-FLAG 
antibody, followed by immunoblotting with antibodies as indicated. B. Establishment of 
HaCaT cells stably expressing FLAG-tagged Ubiquitin. Cell lysates from mock- and 
FLAG-Ubiquitin-transfected cells were immunoprecipitated with anti-FLAG antibody, 
followed by immunoblotting with anti-FLAG antibody. C. HaCaT cells stably 
expressing FLAG-tagged Ubiquitin were treated with TGF-  (100 pM) as indicated. 
Cell lysates were immunoprecipitated with anti-Smad4 antibodies, followed by 
immunoblotting as indicated. Immunoblots of total cell lysates were performed using 
anti-Smad2 and phospho-Smad2 antibodies.
Fig 2. Effects of p300 and c-Ski on the mono-ubiquitination of Smad4.
A - B. 293T cells were transfected with DNA constructs as indicated. Cell lysates were 
immunoprecipitated with anti-FLAG antibody, followed by immunoblotting with 
antibodies as indicated. Total cell lysates were subjected to immunoblotting with 
antibodies as indicated.
Fig 3. Mono-ubiquitinated Smad4 is not found in Smad4 complexes containing 
Smad2 or Smad4 complexes binding target DNA.
A. 293T cells were transfected with DNA constructs as indicated. Cell lysates were 
immunoprecipitated with anti-FLAG (lanes 1 and 2) or anti-Myc (lanes 3 - 5) antibodies, 
followed by immunoblotting with antibodies as indicated. *non-specific band. B. 293T 
cells were transfected with DNA constructs as indicated. Cell lysates were 
immunoprecipitated with anti-FLAG antibody (lanes 1 and 2) or affinity precipitated 
onto a 3x CAGA DNA probe (lanes 3 - 5), followed by immunoblotting with antibodies 
as indicated. 
Fig 4. Subcellular localization of Smad4-Ubiquitin fusion protein.
A. Schematic representation of Smad4 and Smad4-Ubiquitin fusion proteins. B. COS-7 
cells were transfected with DNA constructs as indicated. Immunoblot analysis of total 
cell lysates was performed using anti-FLAG antibody. C. COS-7 cells were transfected 
with DNA constructs as indicated. Cells were cultured in the presence or absence of 
leptomycin B (LMB) (2 ng/ml) for 1 h. Subcellular localization of Smad4 and 
Smad4-Ub was analyzed using anti-FLAG antibody. Nuclei were stained with 
Hoechst33342. Graph shows the percentage of cells containing the indicated grade of 
nuclear staining (right). N=C, nuclear staining as strong as cytoplasmic staining; N>C, 
nuclear staining stronger than cytoplasmic staining; N<C, cytoplasmic staining stronger 
than nuclear staining. D. Proposed scheme of mono-ubiquitination of Smad4. TGF-
stimulation phosphorylates C-terminus of R-Smad. Phosphorylated R-Smad forms a 
complex with Smad4. The Smad complex translocates into the nucleus and binds to the 
target gene. p300 associates with the Smad complex on the DNA, acetylates histones 
and activates transcription. At the same time, p300 induces mono-ubiquitination of 
Smad4 causing dissociation from R-Smad and DNA. c-Ski competes with p300 for 
binding to the Smad complex and suppresses Smad4 mono-ubiquitination and turnover 
of the complex.
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